クリングルファーマ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4884/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/08/05 | 日証協 | 511,300株 | +8.9% | 161,300株 | -40.61% | 536,206株 | +2.21% | 61,300株 | -49.51% |
2022/07/29 | 日証協 | 469,500株 | +11.44% | 271,600株 | +4.1% | 524,608株 | +9.24% | 121,400株 | +78.53% |
2022/07/22 | 日証協 | 421,300株 | +13.19% | 260,900株 | -47.06% | 480,229株 | +8.22% | 68,000株 | -78.5% |
2022/07/15 | 日証協 | 372,200株 | +196.1% | 492,800株 | +572.31% | 443,772株 | +10.47% | 316,217株 | +21.04% |
2022/07/08 | 日証協 | 125,700株 | +39.36% | 73,300株 | -9.39% | 401,727株 | +9.16% | 261,256株 | +16.74% |
2022/07/01 | 日証協 | 90,200株 | +21.4% | 80,900株 | +964.47% | 368,001株 | -1.63% | 223,800株 | +111.53% |
2022/06/24 | 日証協 | 74,300株 | -7.47% | 7,600株 | -15.56% | 374,113株 | -1.06% | 105,800株 | -48.11% |
2022/06/17 | 日証協 | 80,300株 | -1.71% | 9,000株 | -33.33% | 378,113株 | -3.57% | 203,900株 | -10.92% |
2022/06/10 | 日証協 | 81,700株 | +2% | 13,500株 | +3275% | 392,113株 | -1.41% | 228,900株 | +87.01% |
2022/06/03 | 日証協 | 80,100株 | -2.2% | 400株 | -84% | 397,713株 | -0.38% | 122,400株 | -49.11% |
2022/05/27 | 日証協 | 81,900株 | +2.76% | 2,500株 | -32.43% | 399,215株 | -2.42% | 240,502株 | +45.23% |
2022/05/20 | 日証協 | 79,700株 | +3.37% | 3,700株 | -88.86% | 409,113株 | +10.63% | 165,600株 | +699.58% |
2022/05/13 | 日証協 | 77,100株 | +9.36% | 33,200株 | +1975% | 369,802株 | -5.28% | 20,711株 | +568.1% |
2022/05/06 | 日証協 | 70,500株 | +11.37% | 1,600株 | -93.13% | 390,402株 | +1.69% | 3,100株 | -97.09% |
2022/04/28 | 日証協 | 63,300株 | +8.21% | 23,300株 | +40.36% | 383,902株 | -0.21% | 106,500株 | -52.09% |
2022/04/22 | 日証協 | 58,500株 | +10.38% | 16,600株 | -58.5% | 384,701株 | +0.18% | 222,301株 | +59.8% |
2022/04/15 | 日証協 | 53,000株 | -8.46% | 40,000株 | +74.67% | 384,001株 | +36.71% | 139,108株 | +1498.94% |
2022/04/08 | 日証協 | 57,900株 | -19.69% | 22,900株 | -58.96% | 280,893株 | -3.4% | 8,700株 | -76.23% |
2022/04/01 | 日証協 | 72,100株 | -28.04% | 55,800株 | +274.5% | 290,793株 | -2.91% | 36,608株 | +195.23% |
※株式分割は考慮していませんのでご注意ください。
Page Top